Boosting PET recycling with higher standards for laboratory experiments

In principle, PET molecules can be broken down into their basic building blocks using suitable enzymes. In practice, however, these approaches are difficult to transfer to an industrial scale. A new study shows how raising the bar in laboratory experiments could help identify promising enzymes for up-scaling and thus accelerate the development of industrial enzymatic plastics degradation.

In principle, PET molecules can be broken down into their basic building blocks using suitable enzymes. In practice, however, these approaches are difficult to transfer to an industrial scale. A new study shows how raising the bar in laboratory experiments could help identify promising enzymes for up-scaling and thus accelerate the development of industrial enzymatic plastics degradation. © HZB/Frank Lennartz, Gert Weber

Many enzymes promise to break down plastic. But what works well in the lab often fails on a large scale. Now a new study by Gert Weber, HZB, Uwe Bornscheuer, University of Greifswald, and Alain Marty, Chief Scientific Officer of Carbios, shows how raising the bar for laboratory experiments could help identify promising approaches more quickly. The team demonstrated the new standards on four newly discovered enzymes.

From time to time, media reports of major advances in the recycling of polyethylene terephthalate (PET). This is thanks to newly discovered enzymes, breaking down plastic into its constituent parts. However, the success story from the academic laboratory is usually followed by silence. PET accounts for 18% of the world’s plastic production, making it one of the most important plastics in terms of volume. Biotech company Carbios, for example, is building a plant in the north east of France by 2025. This plant will be able to recycle 50.000 tons of PET per year. They are interested to find the best possible enzymes for their industrial setup and have realised that many results from laboratory research cannot be transferred to a larger scale.

Upscaling experiments on PET recycling is difficult

“Some enzymes work great in laboratory experiments for a few hours, but they lose their activity very quickly and the substrate is not completely degraded,” says HZB expert Gert Weber. This is not a problem in the test tube in the laboratory, but it is when used in a large bioreactor. Together with the biotech company Carbios, Uwe Bornscheuer and Gert Weber show how new enzymes for PET degradation can be better compared with each other. “In order to allow upscaling later, many parameters must be within a narrow range even in laboratory experiments. The starting material must be precisely defined and the test protocols must be more standardised in order to better assess the performance of the enzymes and their application on an industrial scale,” explains Bornscheuer. The researchers have therefore developed a standardised PET hydrolysis protocol that defines reaction conditions relevant for hydrolysis on a larger scale. In particular, two PET materials were used, firstly a defined PET film and secondly PET granulate from waste bottles, as used by Carbios on a technical scale. They used these materials to test four recently discovered PET-decomposing enzymes: LCC-ICCG, FAST-PETase, HotPETase and PES-H1L92F/Q94Y.

When experimenting under this protocol, they found that two of these enzymes, FAST-PETase and HotPETase, were less suitable for large-scale use. This is mainly due to their relatively low depolymerisation rates. PES-H1L92F/Q94Y performed better. The fourth candidate, LCC-ICCG, outperformed the other enzymes by far: LCC-ICCG converts 98% of PET into the monomeric products terephthalic acid (TPA) and ethylene glycol (EG) in 24 hours. “In addition, we were able to reduce the amount of enzyme required for LCC-ICCG by a factor of 3 and the reaction temperature from 72 to 68 °C, which makes the use of this enzyme more economical,” says Bornscheuer.

Higher standards for experiments on PET recycling

“We should think about industrial applications already in our laboratory research,” says Gert Weber. After all, we are dealing with one of the really big problems of our time. Plastics are still being produced again and again from fossil raw materials, recycling rates are low and so far, it has mostly been a case of “downcycling” to inferior quality. Plastic waste can now be found in all bodies of water and soil and thus in the food chain. Progress is therefore urgent. “With these standards, we can do something to separate the wheat from the chaff more quickly.”

arö

  • Copy link

You might also be interested in

  • Protein crystallography at BESSY II: faster, better and more and more automatic
    Interview
    04.03.2026
    Protein crystallography at BESSY II: faster, better and more and more automatic
    Many diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with  Manfred Weiss, head of the research group for macromolecular crystallography. 
  • Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. Uhl
    News
    02.03.2026
    Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. Uhl
    Alexander R. Uhl, UBC Okanagan School of Engineering in Kelowna, Canada, aims to develop with Roel van de Krol from the HZB Institute for Solar Fuels an efficient and inexpensive photoelectrolyser for producing hydrogen using sunlight. His stay is being funded by the Alexander von Humboldt Foundation.
  • 5000th protein structure at BESSY II: Starting point for a COVID drug
    Science Highlight
    26.02.2026
    5000th protein structure at BESSY II: Starting point for a COVID drug
    Many proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.